Cite
[The efficacy of ethylmethylhydroxypyridine succinate in patients with cerebrovascular pathology complicated with diabetes mellitus and metabolic syndrome]
MLA
E V Ekusheva, and E V Biryukova. “[The Efficacy of Ethylmethylhydroxypyridine Succinate in Patients with Cerebrovascular Pathology Complicated with Diabetes Mellitus and Metabolic Syndrome].” Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova, vol. 120, no. 12, Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....91be94f193f24e0a3b5f27b8439d4cf0&authtype=sso&custid=ns315887.
APA
E V Ekusheva, & E V Biryukova. (2021). [The efficacy of ethylmethylhydroxypyridine succinate in patients with cerebrovascular pathology complicated with diabetes mellitus and metabolic syndrome]. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova, 120(12).
Chicago
E V Ekusheva, and E V Biryukova. 2021. “[The Efficacy of Ethylmethylhydroxypyridine Succinate in Patients with Cerebrovascular Pathology Complicated with Diabetes Mellitus and Metabolic Syndrome].” Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 120 (12). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....91be94f193f24e0a3b5f27b8439d4cf0&authtype=sso&custid=ns315887.